1. 206 An immune-competent tumor organoid platform to test novel immune checkpoint combinations targeting the receptor CD47 in triple negative breast cancer. (10th December 2020) Authors: Stirling, Elizabeth; Willey-Shelkey, Ethan; Wilson, Adam; Skardal, Aleksander; Triozzi, Pierre; Terabe, Masaki; Miller, Lance; Soker, Shay; Soto-Pantoja, David Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association of tumor and plasma microRNA expression with tumor monosomy-3 in patients with uveal melanoma. Issue 1 (December 2016) Authors: Triozzi, Pierre; Achberger, Susan; Aldrich, Wayne; Crabb, John; Saunthararajah, Yogen; Singh, Arun Journal: Clinical epigenetics Issue: Volume 8:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Circulating tumor cells in uveal melanoma. (January 2011) Authors: Torres, Virginia; Triozzi, Pierre; Eng, Charis; Tubbs, Raymond; Schoenfiled, Lynn; Crabb, John W; Saunthararajah, Yogen; Singh, Arun D Journal: Future oncology Issue: Volume 7:Number 1(2011) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Development of a personalized cellular ex-vivo cbl-b silencing cancer immunotherapy. (6th November 2014) Authors: Lametschwandtner, Guenther; Loibner, Hans; Sachet, Monika; Hayden, Hubert; Hassler, Michaela; Schuster, Manfred; Salzberg, Marc; Triozzi, Pierre; Friedl, Josef Journal: Journal for immunotherapy of cancer Issue: Volume 2(2014)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase I clinical trial of adoptive cellular immunotherapy with APN401 in patients with solid tumors. (4th November 2015) Authors: Triozzi, Pierre; Kooshki, Mitra; Alistar, Angela; Bitting, Rhonda; Neal, Amy; Lametschwandtner, Guenther; Loibner, Hans Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase I clinical trial of adoptive cellular immunotherapy with APN401 in patients with solid tumors. Issue 2 (December 2015) Authors: Triozzi, Pierre; Kooshki, Mitra; Alistar, Angela; Bitting, Rhonda; Neal, Amy; Lametschwandtner, Guenther; Loibner, Hans Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase IIIb safety results from an expanded-access protocol of talimogene laherparepvec for patients with unresected, stage IIIB–IVM1c melanoma. Issue 1 (February 2018) Authors: Chesney, Jason; Awasthi, Sanjay; Curti, Brendan; Hutchins, Laura; Linette, Gerald; Triozzi, Pierre; Tan, Marcus C.B.; Brown, Russell E.; Nemunaitis, John; Whitman, Eric; Windham, Christopher; Lutzky, Jose; Downey, Gerald F.; Batty, Nicolas; Amatruda, Thomas Journal: Melanoma research Issue: Volume 28:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Treatment of a cancer patient by an adoptive cell therapy protocol combining DC vaccination with cbl-b ex vivo silencing. (4th November 2015) Authors: Sachet, Monika; Lametschwandtner, Guenther; Hayden, Hubert; Hassler, Michaela; Loibner, Hans; Triozzi, Pierre; Friedl, Josef Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Treatment of a cancer patient by an adoptive cell therapy protocol combining DC vaccination with cbl-b ex vivo silencing. Issue 2 (December 2015) Authors: Sachet, Monika; Lametschwandtner, Guenther; Hayden, Hubert; Hassler, Michaela; Loibner, Hans; Triozzi, Pierre; Friedl, Josef Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Tumor mutational burden is a determinant of immune-mediated survival in breast cancer. (3rd October 2018) Authors: Thomas, Alexandra; Routh, Eric D.; Pullikuth, Ashok; Jin, Guangxu; Su, Jing; Chou, Jeff W.; Hoadley, Katherine A.; Print, Cristin; Knowlton, Nick; Black, Michael A.; Demaria, Sandra; Wang, Ena; Bedognetti, Davide; Jones, Wendell D.; Mehta, Gaurav A.; Gatza, Michael L.; Perou, Charles M.; Page, Da... Journal: Oncoimmunology Issue: Volume 7:Number 10(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗